These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30377763)

  • 1. Coexistence of t(5;17)/NPM1-RARA and t(9;22)/BCR-ABL1 in chronic myeloid leukemia at initial diagnosis.
    Li Y; Shao H; Fu B
    Ann Hematol; 2019 May; 98(5):1319-1321. PubMed ID: 30377763
    [No Abstract]   [Full Text] [Related]  

  • 2. Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient.
    Zámečníkova A; Al Bahar S; Pandita R
    Hematology; 2012 Nov; 17(6):321-4. PubMed ID: 22989955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 4. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional cytogenetics and FISH in the detection of BCR/ABL fusion in chronic myeloid leukemia (CML).
    Mark HF; Sokolic RA; Mark Y
    Exp Mol Pathol; 2006 Aug; 81(1):1-7. PubMed ID: 16729999
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
    Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
    Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel e8a2 BCR-ABL1 intronic fusion through insertion of a chromosome 22 BCR gene fragment into chromosome 9 in an atypical Philadelphia (Ph) chromosome chronic myeloid leukemia patient.
    Chen L; Wu Y; You Y; Xiao M; Yao Y; Li W
    Leuk Lymphoma; 2016 Dec; 57(12):2930-2933. PubMed ID: 27118564
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetic diagnosis of chronic myeloid leukemia].
    Kato C; Naoe T
    Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A masked BCR/ABL rearrangement in a case of chronic myeloid leukemia with translocation t(3;9)(p14;q34).
    Bennour A; Sennana H; Laatiri MA; Khelif A; Saad A
    Cancer Genet Cytogenet; 2008 Feb; 181(1):72-4. PubMed ID: 18262060
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation - First case series from a single institution.
    Young PE; Kanagal-Shamanna R; Hu S; Tang G; Thakral B; Daver N; Issa GC; Medeiros LJ; Konoplev S
    Leuk Res; 2021 Dec; 111():106685. PubMed ID: 34438119
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion.
    Ha J; Cheong JW; Shin S; Lee ST; Choi JR
    Ann Lab Med; 2016 May; 36(3):287-9. PubMed ID: 26915625
    [No Abstract]   [Full Text] [Related]  

  • 13. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
    Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
    Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
    [No Abstract]   [Full Text] [Related]  

  • 14. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.
    Bacher U; Haferlach T; Alpermann T; Zenger M; Hochhaus A; Beelen DW; Uppenkamp M; Rummel M; Kern W; Schnittger S; Haferlach C
    Br J Haematol; 2011 Mar; 152(6):713-20. PubMed ID: 21275954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and spectrum of atypical BCR-ABL1 transcripts in chronic myeloid leukemia.
    Kearney L; Crampe M; Langabeer SE
    Exp Oncol; 2020 Mar; 42(1):78-79. PubMed ID: 32231188
    [No Abstract]   [Full Text] [Related]  

  • 16. Variant e19a2 BCR-ABL1 fusion transcript in typical chronic myeloid leukemia.
    Tutulan-Cunita AC; Chirieac SM; Mocanu G; Luca C; Costache M; Lungeanu A; Arghir A
    Clin Lab; 2011; 57(9-10):785-8. PubMed ID: 22029197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of the bcr/abl probe test in the evaluation of chronic myeloid leukemia patients.
    Yazici H; Sengün Z; Aktan M; Aktuglu G; Uskent N; Dalay N
    J Exp Clin Cancer Res; 1997 Mar; 16(1):105-9. PubMed ID: 9148870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
    Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
    Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New breakpoints of t(9;22) translocation in chronic myeloid leukemia].
    Misiurin AV; Surin VL; Tagiev AF
    Bioorg Khim; 1999 Mar; 25(3):234-6. PubMed ID: 10382043
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.
    Moore FR; Yang F; Press RD
    Methods Mol Biol; 2013; 999():25-39. PubMed ID: 23666688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.